Shree Mangal Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.40 M
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
About Shree Mangal Ayurveda
Shree Mangal Ayurveda Private Limited (SMAPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 November 2011 and has a history of 13 years and two months. Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹3.00 M.
Rubi Rani and Shiv Charan serve as directors at the Company.
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100PB2011PTC035690
- Company No.
035690
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Shree Mangal Ayurveda Private Limited offer?
Shree Mangal Ayurveda Private Limited offers a wide range of products and services, including Medical Treatment Services, Jaundice Treatment, Ayurvedic Medicine, Leucorrhoea Herbal Capsule Tablet, Homeopathic Drugs, Homeopathic Triturated Medicines, Herbal Oil, Herbal Medicinal Oil, Ayurvedic Digestive Medicine, Ayurvedic Digestive Powder.
Who are the key members and board of directors at Shree Mangal Ayurveda?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rubi Rani  | Director | 28-Nov-2011 | Current |
| Shiv Charan | Director | 28-Nov-2011 | Current |
Financial Performance of Shree Mangal Ayurveda.
Shree Mangal Ayurveda Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shree Mangal Ayurveda?
In 2017, Shree Mangal Ayurveda had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2012 | Uco Bank | ₹3.00 M | Open |
How Many Employees Work at Shree Mangal Ayurveda?
Unlock and access historical data on people associated with Shree Mangal Ayurveda, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Mangal Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Mangal Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.